Comissão científica
Colaboradores
Conducted at Peking University Cancer Hospital & Institute, this randomized controlled trial was able to prove that early multidisciplinary treatment can increase the quality and survival of patients with metastatic gastroesophageal cancer. “These tumors, when locally advanced, can obstruct the feeding route, causing dysphagia and inability to feed orally,” explains Thais Passarini, a clinical oncologist and physician of the Continuous Care team at Oncoclínicas Group in Belo Horizonte (MG).
The results of this study suggest that nutritional and psychological intervention instituted before the start of chemotherapy improves the prognosis of patients with this type of aggressive tumor, whose diagnosis is usually made only in advanced or metastatic stages.
According to Mariana Vargas Gil, a clinical oncologist at Oncoclínicas in Rio de Janeiro, “although it plays an important role in patient tolerance to treatment and in coping with it, interdisciplinary support, in general, is not part of the mandatory protocol. And, in this study, it was possible to prove that “early care, which included nutritional and psychological demands, which are very important in gastroesophageal treatment, is essential to have quality benefits and patient survival,” as explained by Sarah Ananda Gomes, MD, leader of the palliative care/continuous care specialty at Oncoclínicas Group.
Access our website and read the full article.
